Pharmaceutical - Pharmaceutical, Analgesia

Filter

Current filters:

PharmaceuticalAnalgesia

Popular Filters

Acute pain market to grow less than 0.5% between 2013 and 2023, says new research

Acute pain market to grow less than 0.5% between 2013 and 2023, says new research

24-10-2014

The acute pain market will experience only minimal growth between 2013 and 2023, according to biopharma…

AnalgesiaCelebrexDecision Resources GroupMarkets & MarketingPharmaceutical

Novartis is fined by Indian pricing authority over Voveran

Novartis is fined by Indian pricing authority over Voveran

14-10-2014

Swiss pharma major Novartis has received a penalty charge of 3 billion rupees from the Indian National…

AnalgesiadiclofenacIndiaLegalNovartisPharmaceutical

Relmada appoints Julie Chen as Director of Finance and Operations

02-10-2014

US pain therapeutic specialists Relmada Therapeutics has appointed Julie Chen as its Director of Finance…

AnalgesiaBoardroomPharmaceuticalRelmada TherapeuticsUSA

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

22-09-2014

UK-based Skyepharma, an oral and inhalation drug delivery company, has given notice to CRC European Loan…

AnalgesiaExparelFinancialPacira PharmaceuticalsPharmaceuticalSkyepharmaUKUSA

US DEA publishes final rule to reschedule hydrocodone combination products

US DEA publishes final rule to reschedule hydrocodone combination products

22-08-2014

The US Drug Enforcement Administration (DEA) has today published in the Federal Register the Final Rule…

AnalgesiaPharmaceuticalRegulationUS Drug Enforcement AdministrationUSA

Access and Norgine to partner on MuGard in European territories

Access and Norgine to partner on MuGard in European territories

07-08-2014

Emerging biopharma company Access Pharmaceuticals has entered into an exclusive license agreement with…

Access PharmaceuticalsAccess Pharmaceuticals, Inc.AnalgesiaEuropeMarkets & MarketingMucositisMuGardNorginePharmaceutical

Daiichi Sankyo and Charleston Laboratories sign collaboration deal worth up to $650 million

Daiichi Sankyo and Charleston Laboratories sign collaboration deal worth up to $650 million

07-08-2014

Japanese drug major Daiichi Sankyo and privately-held Charleston Laboratories, through its wholly owned…

AnalgesiaCharleston LaboratoriesDaiichi SankyoHydrocodone combination productsJapanLicensingMorphinansPharmaceuticalUSA

Prescription drug abuse affects one in four of Americans

Prescription drug abuse affects one in four of Americans

05-08-2014

One in four Americans admits that they have abused prescription drugs, according to a new national survey…

AnalgesiaEgalet CorporationHealthcareNational Centers for Disease Control and PreventionPharmaceuticalPrescription drug abusePurdue PharmaTarginiqUSA

FDA approves Purdue’s abuse-deterrent opioid Targiniq ER for pain-management

FDA approves Purdue’s abuse-deterrent opioid Targiniq ER for pain-management

25-07-2014

The US Food and Drug Administration has approved privately-held USA-based Purdue Pharma’s abuse-deterrent…

AlcoholsAnalgesiaChemistryNaloxonePharmaceuticalPurdue PharmaRegulationTarginiqUSA

Glenmark opens new MAb manufacturing site in Switzerland

Glenmark opens new MAb manufacturing site in Switzerland

04-06-2014

Glenmark Pharmaceuticals SA (GPSA), a wholly-owned subsidiary of India’s Glenmark Pharmaceuticals,…

AnalgesiaEuropeGlenmark PharmaceuticalsIndiaMonoclonal antibodiesPharmaceuticalProduction

US FDA grants Sativex fast track status for cancer pain

US FDA grants Sativex fast track status for cancer pain

28-04-2014

UK-based GW Pharmaceuticals, which focuses on its proprietary cannabinoid product platform, today announced…

Advanced cancerAnalgesiaCancerGW PharmaceuticalsOncologyOptimized chronic opioid therapyPainPharmaceuticalRegulationSativexTreatment of pain in patients with advanced cancerUK

SI Group acquires ibuprofen and antioxidants from Albemarle Corp

SI Group acquires ibuprofen and antioxidants from Albemarle Corp

17-04-2014

Family-owned US chemical developer and manufacturer SI Group has signed a deal to acquire the antioxidants,…

AlbemarleAnalgesiaibuprofenMergers & AcquisitionsPharmaceuticalUSA

Executive Q&A: Bob Radie, chief executive and president of Egalet

Executive Q&A: Bob Radie, chief executive and president of Egalet

11-04-2014

In an interview with The Pharma Letter, Egalet Corporation’s chief executive Bob Radie discusses the…

AnalgesiaChemistryChief executiveCombination productsEgalet CorpEgalet CorporationInterviewsPharmaceuticalSevere chronic painUSA

Study: Half of veterans prescribed medical opioids continue to use them chronically

Study: Half of veterans prescribed medical opioids continue to use them chronically

07-03-2014

A study of nearly 1 million veterans who receive opioids to treat painful conditions found that more…

AnalgesiaHealthcarePharmaceuticalResearchUSA

FDA says Durect’s pain relief drug Posidur needs additional safety studies

FDA says Durect’s pain relief drug Posidur needs additional safety studies

13-02-2014

US drugmaker Durect Corp says that the US Food and Drug Administration has issued a Complete Response…

AnalgesiaDurectPharmaceuticalPosidurRegulationUSA

Altus signs $4 million agreement with Zogenix to license Zohydro ER

04-11-2013

Altus Pharmaceuticals has entered into an agreement with Zogenix to develop abuse deterrent formulations…

AnalgesiaLicensingNorth AmericaPharmaceuticalZogenixZohydro

Orexo’s Zubsolv could take market share from Suboxone, report suggests

Orexo’s Zubsolv could take market share from Suboxone, report suggests

30-10-2013

Edison Equity Research analysts say that expected new clinical data from Swedish drug developer Orexo…

AnalgesiaFinancialMarkets & MarketingNorth AmericaOrexo ABPharmaceuticalReckitt BenckiserZubsolv

Zogenix shares leap after FDA approval for Zohydro ER

Zogenix shares leap after FDA approval for Zohydro ER

28-10-2013

Shares of Zogenix rocketed on Friday after the US Food and Drug Administration approved Zohydro ER extended-release…

AnalgesiaNorth AmericaPharmaceuticalRegulationZogenixZohydro

FDA calls for reclassification of codeine combo medications to stricter schedules

FDA calls for reclassification of codeine combo medications to stricter schedules

25-10-2013

The US Food and Drug Administration has indicated that it wants to see the classification of codeine-containing…

AnalgesiaHydrocodone Bitartrate and AcetaminophenNorth AmericaPharmaceuticalRegulation

Pfizer to continue Remoxy pain relief development

Pfizer to continue Remoxy pain relief development

24-10-2013

US pharma giant Pfizer will continue the development program for Remoxy Extended-Release Capsules CII,…

AnalgesiaNorth AmericaPfizerPharmaceuticalRemoxyResearch

Iroko’s pain relief drug effective at low doses

Iroko’s pain relief drug effective at low doses

22-10-2013

Iroko Pharmaceuticals has announced that the US Food and Drug Administration has approved Zorvolex capsules…

AnalgesiaIrokoNorth AmericaPharmaceuticalRegulationZorvolex

Mixed results for Pfizer’s two Lyrica Phase IIIb studies

Mixed results for Pfizer’s two Lyrica Phase IIIb studies

21-10-2013

Pfizer has announced mixed results from two Phase IIIb studies of Lyrica capsules CV in patients with…

AnalgesiaLyricaNorth AmericaPfizerPharmaceuticalResearch

UK’s medicines watchdog recalls five Wockhardt medicines

UK’s medicines watchdog recalls five Wockhardt medicines

18-10-2013

The UK’s Medicines and Healthcare products Regulatory Agency has recalled five medicines made by Indian…

AnalgesiaDiabetesEuropeGliclazidePharmaceuticalProductionRegulationWockhardt

Back to top